TheraRadar
Data updated: May 26, 2026

TECHNESCAN MAG3 (technetium tc-99m mertiatide kit)

Renal Approved 1990-06-15

TECHNESCAN MAG3 is indicated for the treatment of Congenital Abnormality; Acquired Abnormality; Renal Failure; Urinary Tract Obstruction; Calculi.

Source: FDA Label • CURIUM
2
Indications
--
Phase 3 Trials
35
Years on Market

Details

Status
Prescription
First Approved
1990-06-15
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

TECHNESCAN MAG3 Approval History

1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
9 FDA actions from 1990 to 2014
Jul 2014 SUPPL
Mfg · Manufacturing (CMC)
Mar 2001 SUPPL
Mfg · Manufacturing (CMC)
Apr 1998 SUPPL
Mfg · Manufacturing (CMC)

What TECHNESCAN MAG3 Treats

5 indications

TECHNESCAN MAG3 is approved for 5 conditions since its original approval in 1990. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Congenital Abnormality
  • Acquired Abnormality
  • Renal Failure
  • Urinary Tract Obstruction
  • Calculi
Source: FDA Label

TECHNESCAN MAG3 Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

TECHNESCAN MAG3 FDA Label Details

Indications & Usage

TECHNESCAN MAG3 is indicated for the treatment of Congenital Abnormality; Acquired Abnormality; Renal Failure; Urinary Tract Obstruction; Calculi.

Track TECHNESCAN MAG3 with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.